SCHEMBL1929669

SCHEMBL1929669

CCc1oc(-c2cccc3ccccc23)nc1CI

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 9/20 0.45
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 8/20 0.45
HSD17B10 Q99714 7/20 0.45
GAA P10253 5/20 0.45
CASP1 P29466 4/20 0.45
CASP7 P55210 4/20 0.45
ALOX12 P18054 4/20 0.45
TSHR P16473 3/20 0.45
HPGD P15428 6/20 0.43
GLA P06280 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 5/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 2/20 0.42
HCRTR1 O43613 1/20 0.42
MAPK1 P28482 2/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1050628 0.82 NPC1 (0.46) ALDH1A1KDM4EHSD17B10TSHRHPGD
SCHEMBL1051302 0.82 KDM4E (0.53) ALOX15ALDH1A1KDM4EHSD17B10GAA
SCHEMBL1049954 0.75 HEXA (0.34)
SCHEMBL1929990 0.74 CYP1A2 (0.46) ALDH1A1KDM4EHSD17B10TSHRHPGD
SCHEMBL17831844 0.74 ALOX15 (0.66) ALOX15ALDH1A1KDM4EHSD17B10GAA
SCHEMBL14541590 0.70 ALOX15 (0.59) ALOX15ALDH1A1KDM4EHSD17B10GAA
SCHEMBL1048319 0.70 PPARG (0.47) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL1930103 0.68 MAPT (0.50) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL29408668 0.67 ALOX15 (0.69) ALOX15ALDH1A1KDM4EHSD17B10GAA
SCHEMBL186871 0.67 ALOX15 (0.69) ALOX15ALDH1A1KDM4EHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7956077-B2 2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2011-06-07 US disclosed
US-20070197613-A1 2-{-3,'2-(PHENYL)-OXAZOL-4-YLMETHOXYL-CYCLOHEXYL METHOXY}-PROPIONIC ACID DERIVATIVES USED AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) LIGANDS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DIABETES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197613-A1 2-{-3,'2-(PHENYL)-OXAZOL-4-YLMETHOXYL-CYCLOHEXYL METHOXY}-PROPIONIC ACID DERIVATIVES USED AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) LIGANDS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DIABETES PPARA, PPARG, PPARD ALOX15 443/4885ALDH1A1 468/4885KDM4E 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.